Jian Ding
Président chez Shanghai Haihe Biopharma Co., Ltd.
Profil
Jian Ding is currently the Chairman at Shanghai Haihe Biopharma Co., Ltd.
since 2011.
Prior to this, he worked as an Independent Director at Hunan Jingfeng Pharmaceutical Co., Ltd.
from 2014 to 2021.
Postes actifs de Jian Ding
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Président | 01/03/2011 |
Anciens postes connus de Jian Ding
| Sociétés | Poste | Fin |
|---|---|---|
| HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. | Directeur/Membre du Conseil | 26/01/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
